Valuation: Ibnsina Pharma

Market Cap 11.59B 229M 200M 185M 170M 321M 22.08B 328M 2.21B 869M 10.82B 861M 842M 37.23B P/E 2026 *
9.45x
P/E 2027 * 6.46x
Enterprise Value 17.41B 344M 301M 278M 256M 482M 33.16B 493M 3.32B 1.31B 16.24B 1.29B 1.26B 55.92B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.17x
Free-Float
70.08%
Yield 2026 *
2.61%
Yield 2027 * 5.04%
1 day+1.05%
1 week-0.78%
Current month-1.46%
1 month-5.66%
3 months+8.49%
6 months+5.99%
Current year-1.88%
1 week 11.2
Extreme 11.2
11.65
1 month 11.2
Extreme 11.2
12.71
Current year 9.63
Extreme 9.63
13.72
1 year 9.63
Extreme 9.63
13.72
3 years 1.78
Extreme 1.78
13.72
5 years 1.1
Extreme 1.101
13.72
10 years 1.1
Extreme 1.101
13.72
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-0.78%+18.92%+395.69% 229M
-5.05%-0.21%-21.97%-28.22% 15.14B
-3.17%-3.17%-28.51%-32.80% 6.93B
+2.53%+4.48%-20.28%-4.43% 6.13B
-2.80%+3.58%-12.04%-30.87% 3.73B
+2.36%+1.93%-38.19%-10.65% 3.25B
-0.66%-1.69%-30.87%-50.25% 3.15B
-3.53%+5.21%+9.30%-30.97% 3.12B
+0.37%-1.07%+99.80% - 2.57B
+0.98%+3.41%-18.38%-1.49% 2.53B
Average -0.79%+0.98%-4.22%+22.89% 4.68B
Weighted average by Cap. -2.03%+0.63%-14.49%-22.60%

Financials

2026 *2027 *
Net sales 89.87B 1.78B 1.55B 1.43B 1.32B 2.49B 171B 2.55B 17.14B 6.74B 83.85B 6.68B 6.53B 289B 101B 2B 1.75B 1.61B 1.49B 2.8B 193B 2.87B 19.29B 7.59B 94.41B 7.52B 7.35B 325B
Net income 1.33B 26.24M 22.93M 21.16M 19.51M 36.77M 2.53B 37.58M 253M 99.49M 1.24B 98.56M 96.4M 4.26B 1.92B 38.07M 33.27M 30.7M 28.3M 53.34M 3.67B 54.53M 367M 144M 1.8B 143M 140M 6.18B
Net Debt 5.82B 115M 101M 92.79M 85.53M 161M 11.08B 165M 1.11B 436M 5.43B 432M 423M 18.68B 5.77B 114M 99.78M 92.08M 84.87M 160M 11B 164M 1.1B 433M 5.39B 429M 419M 18.54B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-07-16 EGP 11.50 +1.05% 7,067,204
26-07-15 EGP 11.38 -0.18% 4,143,450
26-07-14 EGP 11.40 -0.61% 4,162,006
26-07-13 EGP 11.47 -0.26% 4,208,888
26-07-12 EGP 11.50 -0.78% 2,364,911
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.50EGP
Average target price
17.26EGP
Spread / Average Target
+50.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock